Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Zwacka

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Hematology/Oncology Clinics of North America|July 31, 1998
Gene therapy for colon cancerR M Zwacka, M G Dunlop
Biochemical Society Transactions|December 4, 2003
Reactive oxygen species in oncogenic transformationL Behrend, G Henderson, R M Zwacka
Journal of Molecular Medicine (Berlin, Germany)|October 30, 1999
Therapeutic approaches for ischemia/reperfusion injury in the liverC Fan, R M Zwacka, J F Engelhardt
The Journal of Gene Medicine|October 25, 2000
NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cellsR M Zwacka, L Stark, M G Dunlop
Deutsche Medizinische Wochenschrift (1946)|March 8, 2007
[Gene therapy strategies for colorectal cancer]A Mohr, M Lyons, W Mohr, et al.
Cell Death and Differentiation|July 24, 2004
A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c releaseA Mohr, R M Zwacka, K-M Debatin, et al.
Oncogene|July 27, 2007
MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO releaseA Mohr, C Büneker, R P Gough, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2001
Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cellsL A Stark, F V Din, R M Zwacka, et al.
Cell Death & Disease|February 23, 2013
Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effectsR Yu, L Deedigan, S M Albarenque, et al.
Hepatology (Baltimore, Md.)|October 2, 1998
Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradationR M Zwacka, Y Zhang, W Zhou, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|July 31, 1998
Gene therapy for colon cancerR M Zwacka, M G Dunlop
Biochemical Society Transactions|December 4, 2003
Reactive oxygen species in oncogenic transformationL Behrend, G Henderson, R M Zwacka
Journal of Molecular Medicine (Berlin, Germany)|October 30, 1999
Therapeutic approaches for ischemia/reperfusion injury in the liverC Fan, R M Zwacka, J F Engelhardt
The Journal of Gene Medicine|October 25, 2000
NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cellsR M Zwacka, L Stark, M G Dunlop
Deutsche Medizinische Wochenschrift (1946)|March 8, 2007
[Gene therapy strategies for colorectal cancer]A Mohr, M Lyons, W Mohr, et al.
Cell Death and Differentiation|July 24, 2004
A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c releaseA Mohr, R M Zwacka, K-M Debatin, et al.
Oncogene|July 27, 2007
MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO releaseA Mohr, C Büneker, R P Gough, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2001
Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cellsL A Stark, F V Din, R M Zwacka, et al.
Cell Death & Disease|February 23, 2013
Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effectsR Yu, L Deedigan, S M Albarenque, et al.
Hepatology (Baltimore, Md.)|October 2, 1998
Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradationR M Zwacka, Y Zhang, W Zhou, et al.
Pageof 3